Autor: "Lee, Jong Won" - OpacWWW

Skocz do pozycji: 1.

Tytuł:: Survey of clinicians on the use of adjuvant therapy for premenopausal women with breast cancer.
Autorzy:: Lee YW; Division of Breast Surgery, Department of Surgery, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Republic of Korea.
Ahn SH; Department of Surgery, Ewha Womans University College of Medicine, Ewha Womans University Mokdong Hospital, Seoul, Republic of Korea.
Lee YJ; Division of Breast Surgery, Department of Surgery, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Republic of Korea.
Yoo TK; Division of Breast Surgery, Department of Surgery, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Republic of Korea.
Kim J; Division of Breast Surgery, Department of Surgery, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Republic of Korea.
Chung IY; Division of Breast Surgery, Department of Surgery, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Republic of Korea.
Kim HJ; Division of Breast Surgery, Department of Surgery, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Republic of Korea.
Ko BS; Division of Breast Surgery, Department of Surgery, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Republic of Korea.
Lee JW; Division of Breast Surgery, Department of Surgery, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Republic of Korea.
Son BH; Division of Breast Surgery, Department of Surgery, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Republic of Korea.
Lee SB; Division of Breast Surgery, Department of Surgery, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Republic of Korea.; Pokaż więcej
Źródło:: PloS one [PLoS One] 2023 Aug 17; Vol. 18 (8), pp. e0290174. Date of Electronic Publication: 2023 Aug 17 (Print Publication: 2023).
Typ publikacji:: Journal Article
MeSH Terms:: Breast Neoplasms*/drug therapy
Breast Neoplasms*/genetics
Humans ; Female ; Aged ; Adult ; Middle Aged ; Ki-67 Antigen ; Combined Modality Therapy ; Chemotherapy, Adjuvant ; Tamoxifen/therapeutic use ; Aromatase Inhibitors

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 2.

Tytuł:: Survival outcomes of breast cancer patients with recurrence after surgery according to period and subtype.
Autorzy:: Lee YJ; Department of Surgery, Division of Breast Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
Yoo TK; Department of Surgery, Division of Breast Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
Kim J; Department of Surgery, Division of Breast Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
Chung IY; Department of Surgery, Division of Breast Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
Ko BS; Department of Surgery, Division of Breast Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
Kim HJ; Department of Surgery, Division of Breast Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
Lee JW; Department of Surgery, Division of Breast Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
Son BH; Department of Surgery, Division of Breast Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
Ahn SH; Department of Surgery, Division of Breast Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
Lee SB; Department of Surgery, Division of Breast Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.; Pokaż więcej
Źródło:: PloS one [PLoS One] 2023 Jul 27; Vol. 18 (7), pp. e0284460. Date of Electronic Publication: 2023 Jul 27 (Print Publication: 2023).
Typ publikacji:: Review; Journal Article
MeSH Terms:: Breast Neoplasms*/pathology
Humans ; Female ; Disease-Free Survival ; Retrospective Studies ; Neoplasm Recurrence, Local/pathology ; Korea ; Survival Rate ; Receptor, ErbB-2 ; Prognosis ; Receptors, Progesterone

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 3.

Tytuł:: Non-sentinel node metastasis prediction during surgery in breast cancer patients with one to three positive sentinel node(s) following neoadjuvant chemotherapy.
Autorzy:: Chun JW; Division of Breast Surgery, Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine, 88, Olympic-ro 43-gil, Songpa-Gu, Seoul, 05505, Republic of Korea.
Kim J; Division of Breast Surgery, Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine, 88, Olympic-ro 43-gil, Songpa-Gu, Seoul, 05505, Republic of Korea.
Chung IY; Division of Breast Surgery, Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine, 88, Olympic-ro 43-gil, Songpa-Gu, Seoul, 05505, Republic of Korea.
Ko BS; Division of Breast Surgery, Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine, 88, Olympic-ro 43-gil, Songpa-Gu, Seoul, 05505, Republic of Korea.
Kim HJ; Division of Breast Surgery, Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine, 88, Olympic-ro 43-gil, Songpa-Gu, Seoul, 05505, Republic of Korea.
Lee JW; Division of Breast Surgery, Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine, 88, Olympic-ro 43-gil, Songpa-Gu, Seoul, 05505, Republic of Korea.
Son BH; Division of Breast Surgery, Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine, 88, Olympic-ro 43-gil, Songpa-Gu, Seoul, 05505, Republic of Korea.
Ahn SH; Division of Breast Surgery, Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine, 88, Olympic-ro 43-gil, Songpa-Gu, Seoul, 05505, Republic of Korea.
Lee SB; Division of Breast Surgery, Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine, 88, Olympic-ro 43-gil, Songpa-Gu, Seoul, 05505, Republic of Korea. .; Pokaż więcej
Źródło:: Scientific reports [Sci Rep] 2023 Mar 18; Vol. 13 (1), pp. 4480. Date of Electronic Publication: 2023 Mar 18.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Breast Neoplasms*/drug therapy
Breast Neoplasms*/surgery
Breast Neoplasms*/pathology
Sentinel Lymph Node*/surgery
Sentinel Lymph Node*/pathology
Humans ; Female ; Sentinel Lymph Node Biopsy ; Neoadjuvant Therapy ; Retrospective Studies ; Lymph Node Excision ; Nomograms ; Lymph Nodes/surgery ; Lymph Nodes/pathology ; Axilla/pathology

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 4.

Tytuł:: Association between tumor F-fluorodeoxyglucose metabolism and survival in women with estrogen receptor-positive, HER2-negative breast cancer.
Autorzy:: Chae SY; Department of Nuclear Medicine, Uijeongbu Eulji Medical Center, Eulji University School of Medicine, Uijeongbu-si, Republic of Korea.
Park SH; Department of Nuclear Medicine, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, Republic of Korea.
Lee HS; Department of Nuclear Medicine, GangNeung Asan Hospital, University of Ulsan College of Medicine, Gangneung, Republic of Korea.
Ahn JH; Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
Kim SB; Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
Jung KH; Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
Kim JE; Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
Ahn SH; Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
Son BH; Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
Lee JW; Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
Ko BS; Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
Kim HJ; Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
Gong G; Department of Pathology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
Oh JS; Department of Nuclear Medicine, Asan Medical Center, University of Ulsan College of Medicine, 88, Olympic-ro 43-gil, Songpa-gu, Seoul, 05505, Republic of Korea.
Park SY; Department of Clinical Epidemiology and Biostatistics, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.; Department of Statistics and Data Science, Korea National Open University, Seoul, Republic of Korea.
Moon DH; Department of Nuclear Medicine, Asan Medical Center, University of Ulsan College of Medicine, 88, Olympic-ro 43-gil, Songpa-gu, Seoul, 05505, Republic of Korea. .; Pokaż więcej
Źródło:: Scientific reports [Sci Rep] 2022 May 12; Vol. 12 (1), pp. 7858. Date of Electronic Publication: 2022 May 12.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Breast Neoplasms*/metabolism
Fluorodeoxyglucose F18*
Cohort Studies ; Female ; Humans ; Neoplasm Recurrence, Local/diagnostic imaging ; Positron Emission Tomography Computed Tomography/methods ; Positron-Emission Tomography ; Prognosis ; Radiopharmaceuticals/therapeutic use ; Receptors, Estrogen/metabolism

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 5.

Tytuł:: Clinicopathological characteristics and outcomes of malignant adenomyoepithelioma of the breast: a single institution's experience.
Autorzy:: Alqudaihi HMA; Department of Breast Surgery, Asan Medical Center, Collage of Medicine, University of Ulsan, Seoul, Republic of Korea.; Department of General Surgery, Qatif Central Hospital, Ministry of Health, Qatif, Eastern Province, Saudi Arabia.
Lee SB; Department of Breast Surgery, Asan Medical Center, Collage of Medicine, University of Ulsan, Seoul, Republic of Korea.
Son BH; Department of Breast Surgery, Asan Medical Center, Collage of Medicine, University of Ulsan, Seoul, Republic of Korea. .
Ahn SH; Department of Breast Surgery, Asan Medical Center, Collage of Medicine, University of Ulsan, Seoul, Republic of Korea.
Lee JW; Department of Breast Surgery, Asan Medical Center, Collage of Medicine, University of Ulsan, Seoul, Republic of Korea.
Ko BS; Department of Breast Surgery, Asan Medical Center, Collage of Medicine, University of Ulsan, Seoul, Republic of Korea.
Kim HJ; Department of Breast Surgery, Asan Medical Center, Collage of Medicine, University of Ulsan, Seoul, Republic of Korea.
Chung IY; Department of Breast Surgery, Asan Medical Center, Collage of Medicine, University of Ulsan, Seoul, Republic of Korea.
Kim J; Department of Breast Surgery, Asan Medical Center, Collage of Medicine, University of Ulsan, Seoul, Republic of Korea.
Gong G; Department of Pathology, Asan Medical Center, Collage of Medicine, University of Ulsan, Seoul, Republic of Korea.; Pokaż więcej
Źródło:: World journal of surgical oncology [World J Surg Oncol] 2022 Apr 22; Vol. 20 (1), pp. 128. Date of Electronic Publication: 2022 Apr 22.
Typ publikacji:: Journal Article
MeSH Terms:: Adenomyoepithelioma*/pathology
Adenomyoepithelioma*/surgery
Breast Neoplasms*/surgery
Lung Neoplasms*/surgery
Female ; Humans ; Male ; Mastectomy ; Middle Aged ; Retrospective Studies ; Sentinel Lymph Node Biopsy

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 6.

Tytuł:: Is There a Difference in the Diagnosis and Prognosis of Local Recurrence between Autologous Tissue and Implant-Based Breast Reconstruction?
Autorzy:: Min K; Department of Plastic and Reconstructive Surgery, Hanyang University College of Medicine, Seoul, Republic of Korea.
Han HH; Department of Plastic Surgery, Asan Medical Center, University of Ulsan, College of Medicine, Ulsan, Republic of Korea.
Kim EK; Department of Plastic Surgery, Asan Medical Center, University of Ulsan, College of Medicine, Ulsan, Republic of Korea.
Lee SB; Department of Plastic Surgery, Asan Medical Center, University of Ulsan, College of Medicine, Ulsan, Republic of Korea.
Kim J; Department of Plastic Surgery, Asan Medical Center, University of Ulsan, College of Medicine, Ulsan, Republic of Korea.
Chung IY; Department of Plastic Surgery, Asan Medical Center, University of Ulsan, College of Medicine, Ulsan, Republic of Korea.
Kim HJ; Department of Plastic Surgery, Asan Medical Center, University of Ulsan, College of Medicine, Ulsan, Republic of Korea.
Ko BS; Department of Plastic Surgery, Asan Medical Center, University of Ulsan, College of Medicine, Ulsan, Republic of Korea.
Lee JW; Department of Plastic Surgery, Asan Medical Center, University of Ulsan, College of Medicine, Ulsan, Republic of Korea.
Son BH; Department of Plastic Surgery, Asan Medical Center, University of Ulsan, College of Medicine, Ulsan, Republic of Korea.
Ahn SH; Department of Plastic Surgery, Asan Medical Center, University of Ulsan, College of Medicine, Ulsan, Republic of Korea.
Eom JS; Department of Plastic Surgery, Asan Medical Center, University of Ulsan, College of Medicine, Ulsan, Republic of Korea.; Pokaż więcej
Źródło:: The breast journal [Breast J] 2022 Apr 11; Vol. 2022, pp. 9029528. Date of Electronic Publication: 2022 Apr 11 (Print Publication: 2022).
Typ publikacji:: Journal Article
MeSH Terms:: Breast Implants*/adverse effects
Breast Neoplasms*/pathology
Mammaplasty*
Female ; Humans ; Mastectomy ; Neoplasm Recurrence, Local/surgery ; Prognosis ; Retrospective Studies

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 7.

Tytuł:: Improvement of survival in Korean breast cancer patients over a 14-year period: A large-scale single-center study.
Autorzy:: Kim H; Division of Breast Surgery, Department of Surgery, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Republic of Korea.
Lee SB; Division of Breast Surgery, Department of Surgery, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Republic of Korea.
Kim J; Division of Breast Surgery, Department of Surgery, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Republic of Korea.
Chung IY; Division of Breast Surgery, Department of Surgery, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Republic of Korea.
Kim HJ; Division of Breast Surgery, Department of Surgery, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Republic of Korea.
Ko BS; Division of Breast Surgery, Department of Surgery, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Republic of Korea.
Lee JW; Division of Breast Surgery, Department of Surgery, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Republic of Korea.
Son BH; Division of Breast Surgery, Department of Surgery, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Republic of Korea.
Ahn SH; Division of Breast Surgery, Department of Surgery, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Republic of Korea.; Pokaż więcej
Źródło:: PloS one [PLoS One] 2022 Mar 16; Vol. 17 (3), pp. e0265533. Date of Electronic Publication: 2022 Mar 16 (Print Publication: 2022).
Typ publikacji:: Journal Article
MeSH Terms:: Breast Neoplasms*/pathology
Triple Negative Breast Neoplasms*
Disease-Free Survival ; Female ; Humans ; Neoplasm Recurrence, Local ; Prognosis ; Receptor, ErbB-2/metabolism ; Republic of Korea/epidemiology ; Retrospective Studies ; Survival Rate

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 8.

Tytuł:: A nomogram for predicting probability of low risk of MammaPrint results in women with clinically high-risk breast cancer.
Autorzy:: Lee YJ; Division of Breast Surgery, Department of Surgery, Seoul St Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.
Hwang YS; University of Ulsan College of Medicine, Seoul, Republic of Korea.
Kim J; Graduate School of Cancer Science and Policy, National Cancer Center, Goyang-si, Republic of Korea.
Ahn SH; Division of Breast Surgery, Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
Son BH; Division of Breast Surgery, Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
Kim HJ; Division of Breast Surgery, Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
Ko BS; Division of Breast Surgery, Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
Kim J; Division of Breast Surgery, Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
Chung IY; Division of Breast Surgery, Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
Lee JW; Division of Breast Surgery, Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
Lee SB; Division of Breast Surgery, Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea. .; Pokaż więcej
Źródło:: Scientific reports [Sci Rep] 2021 Dec 06; Vol. 11 (1), pp. 23509. Date of Electronic Publication: 2021 Dec 06.
Typ publikacji:: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms:: Breast Neoplasms/*genetics
Breast Neoplasms/*pathology
Axilla/pathology ; Breast/pathology ; Breast Neoplasms/diagnosis ; Female ; Humans ; Lymphatic Metastasis/genetics ; Lymphatic Metastasis/pathology ; Middle Aged ; Nomograms ; Probability ; ROC Curve ; Receptor, ErbB-2/genetics ; Receptors, Progesterone ; Retrospective Studies ; Risk

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 9.

Tytuł:: Germline breast cancer susceptibility genes, tumor characteristics, and survival.
Autorzy:: Ho PJ; Genome Institute of Singapore, Human Genetics, Singapore, Singapore.; Saw Swee Hock School of Public Health, National University of Singapore and National University Health System, Singapore, Singapore.
Khng AJ; Genome Institute of Singapore, Human Genetics, Singapore, Singapore.
Loh HW; Genome Institute of Singapore, Human Genetics, Singapore, Singapore.
Ho WK; School of Mathematical Sciences, Faculty of Science and Engineering, University of Nottingham Malaysia, Jalan Broga, 43500, Semenyih, Selangor, Malaysia.; Cancer Research Malaysia, 1 Jalan SS12/1A, 47500, Subang Jaya, Selangor, Malaysia.
Yip CH; Subang Jaya Medical Centre, Jalan SS 12/1A, 47500, Subang Jaya, Selangor, Malaysia.
Mohd-Taib NA; Department of Surgery, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia.; UM Cancer Research Institute, Kuala Lumpur, Malaysia.
Tan VKM; Department of Breast Surgery, Singapore General Hospital, Singapore, Singapore.; Division of Surgical Oncology, National Cancer Centre Singapore, Singapore, Singapore.
Tan BK; Department of Breast Surgery, Singapore General Hospital, Singapore, Singapore.; Division of Surgical Oncology, National Cancer Centre Singapore, Singapore, Singapore.; Department of General Surgery, Sengkang General Hospital, Singapore, Singapore.
Tan SM; Division of Breast Surgery, Changi General Hospital, Singapore, Singapore.
Tan EY; Department of General Surgery, Tan Tock Seng Hospital, Singapore, 308433, Singapore.; Lee Kong Chian School of Medicine, Singapore, Singapore.; Institute of Molecular and Cell Biology, Singapore, Singapore.
Lim SH; KK Breast Department, KK Women's and Children's Hospital, Singapore, 229899, Singapore.
Jamaris S; Department of Surgery, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia.; UM Cancer Research Institute, Kuala Lumpur, Malaysia.
Sim Y; Department of Breast Surgery, Singapore General Hospital, Singapore, Singapore.; Division of Surgical Oncology, National Cancer Centre Singapore, Singapore, Singapore.
Wong FY; Division of Radiation Oncology, National Cancer Centre Singapore, Singapore, Singapore.
Ngeow J; Lee Kong Chian School of Medicine, Nanyang Technology University, Singapore, Singapore.; Cancer Genetics Service, National Cancer Centre Singapore, Singapore, Singapore.; Oncology Academic Clinical Program, Duke NUS, Singapore, Singapore.
Lim EH; Division of Medical Oncology, National Cancer Centre Singapore, Singapore, Singapore.
Tai MC; Cancer Research Malaysia, 1 Jalan SS12/1A, 47500, Subang Jaya, Selangor, Malaysia.
Wijaya EA; Cancer Research Malaysia, 1 Jalan SS12/1A, 47500, Subang Jaya, Selangor, Malaysia.
Lee SC; Department of Hematology-oncology, National University Cancer Institute, National University Health System, Singapore, 119074, Singapore.
Chan CW; Department of Surgery, University Surgical Cluster, National University Hospital, Singapore, Singapore.
Buhari SA; Department of Surgery, University Surgical Cluster, National University Hospital, Singapore, Singapore.
Chan PMY; Department of General Surgery, Tan Tock Seng Hospital, Singapore, 308433, Singapore.
Chen JJC; Department of General Surgery, Tan Tock Seng Hospital, Singapore, 308433, Singapore.
Seah JCM; Division of Breast Surgery, Changi General Hospital, Singapore, Singapore.
Lee WP; Division of Breast Surgery, Changi General Hospital, Singapore, Singapore.
Mok CW; Division of Breast Surgery, Changi General Hospital, Singapore, Singapore.
Lim GH; KK Breast Department, KK Women's and Children's Hospital, Singapore, 229899, Singapore.
Woo E; KK Breast Department, KK Women's and Children's Hospital, Singapore, 229899, Singapore.
Kim SW; Department of Surgery, Breast Care Center, Daerim St. Mary's Hospital, Seoul, Korea.
Lee JW; Department of Surgery, University of Ulsan College of Medicine and Asan Medical Center, Seoul, Republic of Korea.
Lee MH; Department of Surgery, Soonchunhyang University and Hospital, Seoul, Republic of Korea.
Park SK; Department of Preventive Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea.; Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul, Republic of Korea.; Cancer Research Institute, Seoul National University, Seoul, Republic of Korea.
Dunning AM; Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK.
Easton DF; Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK.; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
Schmidt MK; Division of Molecular Pathology, Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands.
Teo SH; Cancer Research Malaysia, 1 Jalan SS12/1A, 47500, Subang Jaya, Selangor, Malaysia.; Department of Surgery, Faculty of Medicine, University of Malaya, Jalan Universiti, 50630, Kuala Lumpur, Malaysia.
Li J; Genome Institute of Singapore, Human Genetics, Singapore, Singapore. .; Department of Surgery, Yong Loo Lin School of Medicine, National University of Singapore and National University Health System, Singapore, Singapore. .
Hartman M; Saw Swee Hock School of Public Health, National University of Singapore and National University Health System, Singapore, Singapore.; Department of Surgery, University Surgical Cluster, National University Hospital, Singapore, Singapore.; Department of Surgery, Yong Loo Lin School of Medicine, National University of Singapore and National University Health System, Singapore, Singapore.; Pokaż więcej
Źródło:: Genome medicine [Genome Med] 2021 Dec 02; Vol. 13 (1), pp. 185. Date of Electronic Publication: 2021 Dec 02.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Breast Neoplasms*/pathology
BRCA1 Protein/genetics ; Female ; Genetic Predisposition to Disease ; Genetic Testing ; Germ Cells ; Germ-Line Mutation ; Humans ; Odds Ratio

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 10.

Tytuł:: The role of postoperative radiotherapy after primary tumor resection in patients with de novo stage IV breast cancer.
Autorzy:: Kim YJ; Department of Radiation Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.
Kim SS; Department of Radiation Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.
Ahn SD; Department of Radiation Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.
Jung J; Department of Radiation Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.
Ahn SH; Division of Breast Surgery, Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.
Son BH; Division of Breast Surgery, Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.
Lee JW; Division of Breast Surgery, Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.
Kim HJ; Division of Breast Surgery, Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.
Ko BS; Division of Breast Surgery, Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.
Kim SB; Division of Medical Oncology, Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.
Jung KH; Division of Medical Oncology, Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.
Ahn JH; Division of Medical Oncology, Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.
Kim JE; Division of Medical Oncology, Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.
Choi EK; Department of Radiation Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.; Pokaż więcej
Źródło:: Asia-Pacific journal of clinical oncology [Asia Pac J Clin Oncol] 2021 Dec; Vol. 17 (6), pp. 495-505. Date of Electronic Publication: 2020 Nov 11.
Typ publikacji:: Journal Article
MeSH Terms:: Breast Neoplasms*/pathology
Breast Neoplasms*/radiotherapy
Breast Neoplasms*/surgery
Breast ; Female ; Humans ; Mastectomy ; Neoplasm Staging ; Radiotherapy, Adjuvant ; Retrospective Studies ; Survival Rate

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 11.

Tytuł:: Comparison of metabolic changes after neoadjuvant endocrine and chemotherapy in ER-positive, HER2-negative breast cancer.
Autorzy:: Ryu HH; Department of Breast Surgery, University of Ulsan, College of Medicine, Asan Medical Center, 88 Olympic ro 43 gil, song pa gu, Seoul, 138-736, Korea.
Ahn SH; Department of Breast Surgery, University of Ulsan, College of Medicine, Asan Medical Center, 88 Olympic ro 43 gil, song pa gu, Seoul, 138-736, Korea.
Kim SO; Department of Clinical Epidemiology and Biostatistics, University of Ulsan, College of Medicine, Asan Medical Center, Seoul, Korea.
Kim JE; Department of Oncology, University of Ulsan, College of Medicine, Asan Medical Center, Seoul, Korea.
Kim JS; Department of Breast Surgery, University of Ulsan, College of Medicine, Asan Medical Center, 88 Olympic ro 43 gil, song pa gu, Seoul, 138-736, Korea.
Ahn JH; Department of Oncology, University of Ulsan, College of Medicine, Asan Medical Center, Seoul, Korea.
Jung KH; Department of Oncology, University of Ulsan, College of Medicine, Asan Medical Center, Seoul, Korea.
Kim SB; Department of Oncology, University of Ulsan, College of Medicine, Asan Medical Center, Seoul, Korea.
Ko BS; Department of Breast Surgery, University of Ulsan, College of Medicine, Asan Medical Center, 88 Olympic ro 43 gil, song pa gu, Seoul, 138-736, Korea.
Lee JW; Department of Breast Surgery, University of Ulsan, College of Medicine, Asan Medical Center, 88 Olympic ro 43 gil, song pa gu, Seoul, 138-736, Korea.
Son BH; Department of Breast Surgery, University of Ulsan, College of Medicine, Asan Medical Center, 88 Olympic ro 43 gil, song pa gu, Seoul, 138-736, Korea.
Shin HJ; Department of Radiology, University of Ulsan, College of Medicine, Asan Medical Center, Seoul, Korea.
Kim HH; Department of Radiology, University of Ulsan, College of Medicine, Asan Medical Center, Seoul, Korea.
Gong GY; Department of Pathology, University of Ulsan, College of Medicine, Asan Medical Center, Seoul, Korea.
Kim HJ; Department of Breast Surgery, University of Ulsan, College of Medicine, Asan Medical Center, 88 Olympic ro 43 gil, song pa gu, Seoul, 138-736, Korea. .; Pokaż więcej
Źródło:: Scientific reports [Sci Rep] 2021 May 18; Vol. 11 (1), pp. 10510. Date of Electronic Publication: 2021 May 18.
Typ publikacji:: Clinical Trial, Phase III; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms:: Neoadjuvant Therapy*
Breast Neoplasms/*drug therapy
Receptor, ErbB-2/*metabolism
Receptors, Estrogen/*metabolism
Adult ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Breast Neoplasms/metabolism ; Cyclophosphamide/administration & dosage ; Doxorubicin/administration & dosage ; Female ; Goserelin/administration & dosage ; Humans ; Middle Aged ; Prospective Studies ; Tamoxifen/administration & dosage

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 12.

Tytuł:: Prognosis according to clinical and pathologic lymph node status in breast cancer patients who underwent sentinel lymph node biopsy alone after neoadjuvant therapy.
Autorzy:: Lee SB; Division of Breast Surgery, Department of Surgery, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea.
Kim H; Division of Breast Surgery, Department of Surgery, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea.
Kim J; Division of Breast Surgery, Department of Surgery, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea.
Chung IY; Division of Breast Surgery, Department of Surgery, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea.
Kim HJ; Division of Breast Surgery, Department of Surgery, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea.
Ko BS; Division of Breast Surgery, Department of Surgery, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea.
Lee JW; Division of Breast Surgery, Department of Surgery, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea.
Ahn SH; Division of Breast Surgery, Department of Surgery, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea.
Son BH; Division of Breast Surgery, Department of Surgery, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea.; Pokaż więcej
Źródło:: PloS one [PLoS One] 2021 May 18; Vol. 16 (5), pp. e0251597. Date of Electronic Publication: 2021 May 18 (Print Publication: 2021).
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Breast Neoplasms*/drug therapy
Breast Neoplasms*/mortality
Breast Neoplasms*/pathology
Neoadjuvant Therapy*
Sentinel Lymph Node Biopsy*
Adult ; Disease-Free Survival ; Female ; Follow-Up Studies ; Humans ; Lymph Nodes/pathology ; Middle Aged ; Retrospective Studies ; Survival Rate

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 13.

Tytuł:: Sentinel node biopsy alone for breast cancer patients with residual nodal disease after neoadjuvant chemotherapy.
Autorzy:: Chun JW; Division of Breast Surgery, Department of Surgery, University of Ulsan College of Medicine, Asan Medical Center, 88, Olympic-ro 43-gil, Songpa-Gu, Seoul, 05505, Republic of Korea.
Kim J; Division of Breast Surgery, Department of Surgery, University of Ulsan College of Medicine, Asan Medical Center, 88, Olympic-ro 43-gil, Songpa-Gu, Seoul, 05505, Republic of Korea.
Chung IY; Division of Breast Surgery, Department of Surgery, University of Ulsan College of Medicine, Asan Medical Center, 88, Olympic-ro 43-gil, Songpa-Gu, Seoul, 05505, Republic of Korea.
Ko BS; Division of Breast Surgery, Department of Surgery, University of Ulsan College of Medicine, Asan Medical Center, 88, Olympic-ro 43-gil, Songpa-Gu, Seoul, 05505, Republic of Korea.
Kim HJ; Division of Breast Surgery, Department of Surgery, University of Ulsan College of Medicine, Asan Medical Center, 88, Olympic-ro 43-gil, Songpa-Gu, Seoul, 05505, Republic of Korea.
Lee JW; Division of Breast Surgery, Department of Surgery, University of Ulsan College of Medicine, Asan Medical Center, 88, Olympic-ro 43-gil, Songpa-Gu, Seoul, 05505, Republic of Korea.
Son BH; Division of Breast Surgery, Department of Surgery, University of Ulsan College of Medicine, Asan Medical Center, 88, Olympic-ro 43-gil, Songpa-Gu, Seoul, 05505, Republic of Korea.
Ahn SH; Division of Breast Surgery, Department of Surgery, University of Ulsan College of Medicine, Asan Medical Center, 88, Olympic-ro 43-gil, Songpa-Gu, Seoul, 05505, Republic of Korea.
Lee SB; Division of Breast Surgery, Department of Surgery, University of Ulsan College of Medicine, Asan Medical Center, 88, Olympic-ro 43-gil, Songpa-Gu, Seoul, 05505, Republic of Korea. .; Pokaż więcej
Źródło:: Scientific reports [Sci Rep] 2021 Apr 27; Vol. 11 (1), pp. 9056. Date of Electronic Publication: 2021 Apr 27.
Typ publikacji:: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Antineoplastic Combined Chemotherapy Protocols/*therapeutic use
Breast Neoplasms/*drug therapy
Lymph Node Excision/*mortality
Lymph Nodes/*surgery
Neoadjuvant Therapy/*mortality
Neoplasm, Residual/*surgery
Sentinel Lymph Node Biopsy/*mortality
Breast Neoplasms/pathology ; Combined Modality Therapy ; Female ; Follow-Up Studies ; Humans ; Lymph Nodes/pathology ; Middle Aged ; Neoplasm Recurrence, Local/drug therapy ; Neoplasm Recurrence, Local/pathology ; Neoplasm, Residual/drug therapy ; Neoplasm, Residual/pathology ; Prognosis ; Retrospective Studies ; Survival Rate

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 14.

Tytuł:: Analysis of BRCA1/2 variants of unknown significance in the prospective Korean Hereditary Breast Cancer study.
Autorzy:: Kim JH; Department of Surgery, Yongin Severance Hospital, Yonsei University College of Medicine, Yongin, Gyeonggi, Republic of Korea.
Park S; Department of Laboratory Medicine, Keimyung University School of Medicine, Daegu, Republic of Korea.
Park HS; Department of Surgery, Yonsei University College of Medicine, 50-1 Yonseiro, Seodaemun-gu, Seoul, 03722, Republic of Korea. .
Park JS; Hereditary Cancer Clinic, Cancer Prevention Center, Yonsei Cancer Center, Yonsei University College of Medicine, 50-1 Yonseiro, Seodaemun-gu, Seoul, 03722, Republic of Korea. .
Lee ST; Department of Laboratory Medicine, Yonsei University College of Medicine, Seoul, Republic of Korea.
Kim SW; Department of Surgery, Daerim St. Mary's Hospital, Seoul, Republic of Korea.
Lee JW; Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
Lee MH; Department of Surgery, Soonchunhyang University Seoul Hospital, Seoul, Republic of Korea.
Park SK; Department of Preventive Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea.; Cancer Research Institute, Seoul National University, Seoul, Republic of Korea.
Noh WC; Department of Surgery, Korea Institute of Radiological & Medical Science, Korea Cancer Center Hospital, Seoul, Republic of Korea.
Choi DH; Department of Radiation Oncology, Samsung Medical Center, Sungkyunkwan University, Seoul, Republic of Korea.
Han W; Department of Surgery, Cancer Research Institute, Seoul National University College of Medicine, Seoul, Republic of Korea.
Jung SH; Department of Surgery, Chonbuk National University Hospital, Jeonju, Jeollabuk, Republic of Korea.; Pokaż więcej
Źródło:: Scientific reports [Sci Rep] 2021 Apr 19; Vol. 11 (1), pp. 8485. Date of Electronic Publication: 2021 Apr 19.
Typ publikacji:: Journal Article
MeSH Terms:: Mutation*
BRCA1 Protein/*genetics
BRCA2 Protein/*genetics
Breast Neoplasms/*pathology
Genetic Testing/*methods
Hereditary Breast and Ovarian Cancer Syndrome/*pathology
Adult ; Breast Neoplasms/epidemiology ; Breast Neoplasms/genetics ; Female ; Hereditary Breast and Ovarian Cancer Syndrome/epidemiology ; Hereditary Breast and Ovarian Cancer Syndrome/genetics ; Humans ; Prospective Studies ; Republic of Korea/epidemiology
SCR Disease Name:: Breast Cancer, Familial

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 15.

Tytuł:: Usefulness of 3D-surgical guides in breast conserving surgery after neoadjuvant treatment.
Autorzy:: Lee HS; Department of Surgery, Gyeongsang National University School of Medicine and Gyeongsang National University Changwon Hospital, Changwon, Republic of Korea.
Kim HJ; Division of Breast Surgery, Department of Surgery, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Republic of Korea.
Chung IY; Division of Breast Surgery, Department of Surgery, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Republic of Korea.
Kim J; Division of Breast Surgery, Department of Surgery, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Republic of Korea.
Lee SB; Division of Breast Surgery, Department of Surgery, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Republic of Korea.
Lee JW; Division of Breast Surgery, Department of Surgery, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Republic of Korea.
Son BH; Division of Breast Surgery, Department of Surgery, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Republic of Korea.
Ahn SH; Division of Breast Surgery, Department of Surgery, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Republic of Korea.
Kim HH; Department of Radiology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Republic of Korea.
Seo JB; Department of Radiology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Republic of Korea.
Ahn JH; Department of Oncology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Republic of Korea.
Gong G; Department of Pathology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Republic of Korea.
Lee S; Department of Convergence Medicine, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea.
Kim N; Department of Radiology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Republic of Korea. .; Department of Convergence Medicine, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea. .
Ko BS; Division of Breast Surgery, Department of Surgery, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Republic of Korea. .; Pokaż więcej
Źródło:: Scientific reports [Sci Rep] 2021 Feb 09; Vol. 11 (1), pp. 3376. Date of Electronic Publication: 2021 Feb 09.
Typ publikacji:: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Breast*/diagnostic imaging
Breast*/pathology
Breast*/surgery
Breast Neoplasms*/diagnostic imaging
Breast Neoplasms*/pathology
Breast Neoplasms*/therapy
Magnetic Resonance Imaging*
Mastectomy, Segmental*
Neoadjuvant Therapy*
Surgery, Computer-Assisted*
Adult ; Aged ; Biopsy ; Female ; Humans ; Middle Aged ; Prospective Studies

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 16.

Tytuł:: Targeted eicosanoids profiling reveals a prostaglandin reprogramming in breast Cancer by microRNA-155.
Autorzy:: Kim S; Department of Biomedical Sciences, Asan Medical Center, University of Ulsan College of Medicine, Seoul, 05505, South Korea.
Lee ES; Department of Biomedical Sciences, Asan Medical Center, University of Ulsan College of Medicine, Seoul, 05505, South Korea.
Lee EJ; Department of Biomedical Sciences, Asan Medical Center, University of Ulsan College of Medicine, Seoul, 05505, South Korea.
Jung JY; Department of Biomedical Sciences, Asan Medical Center, University of Ulsan College of Medicine, Seoul, 05505, South Korea.
Lee SB; Division of Breast Surgery, Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, 05505, South Korea.
Lee HJ; Department of Pathology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, 05505, South Korea.
Kim J; Division of Breast Surgery, Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, 05505, South Korea.
Kim HJ; Division of Breast Surgery, Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, 05505, South Korea.
Lee JW; Division of Breast Surgery, Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, 05505, South Korea.
Son BH; Division of Breast Surgery, Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, 05505, South Korea.
Gong G; Department of Pathology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, 05505, South Korea.
Ahn SH; Division of Breast Surgery, Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, 05505, South Korea.
Chang S; Department of Biomedical Sciences, Asan Medical Center, University of Ulsan College of Medicine, Seoul, 05505, South Korea. .; Pokaż więcej
Źródło:: Journal of experimental & clinical cancer research : CR [J Exp Clin Cancer Res] 2021 Jan 25; Vol. 40 (1), pp. 43. Date of Electronic Publication: 2021 Jan 25.
Typ publikacji:: Journal Article
MeSH Terms:: Gene Expression Regulation, Neoplastic*
Breast Neoplasms/*etiology
Breast Neoplasms/*metabolism
Eicosanoids/*metabolism
MicroRNAs/*genetics
Prostaglandins/*metabolism
Animals ; Biomarkers ; Breast Neoplasms/mortality ; Breast Neoplasms/pathology ; Cell Line, Tumor ; Chromatin Immunoprecipitation ; Chromatography, Liquid ; Dinoprostone/metabolism ; Disease Models, Animal ; Energy Metabolism ; Female ; Gene Knockdown Techniques ; Humans ; Intramolecular Oxidoreductases/metabolism ; Kruppel-Like Factor 4 ; Kruppel-Like Transcription Factors/metabolism ; Lipocalins/metabolism ; Metabolome ; Metabolomics/methods ; Prognosis ; Tandem Mass Spectrometry

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 17.

Tytuł:: Potential of MALDI-TOF-based serum N-glycan analysis for the diagnosis and surveillance of breast cancer.
Autorzy:: Lee JW; Division of Breast Surgery, Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine, 88, Olympic-ro 43-gil, Songpa-gu, Seoul, 05505, Republic of Korea.
Lee K; R&D Center, NOSQUEST Inc., 660, Daewangpangyo-ro, Bundang-gu, Seongnam-si, Gyeonggi-do, 13494, Republic of Korea.
Ahn SH; Division of Breast Surgery, Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine, 88, Olympic-ro 43-gil, Songpa-gu, Seoul, 05505, Republic of Korea.
Son BH; Division of Breast Surgery, Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine, 88, Olympic-ro 43-gil, Songpa-gu, Seoul, 05505, Republic of Korea.
Ko BS; Division of Breast Surgery, Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine, 88, Olympic-ro 43-gil, Songpa-gu, Seoul, 05505, Republic of Korea.
Kim HJ; Division of Breast Surgery, Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine, 88, Olympic-ro 43-gil, Songpa-gu, Seoul, 05505, Republic of Korea.
Chung IY; Division of Breast Surgery, Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine, 88, Olympic-ro 43-gil, Songpa-gu, Seoul, 05505, Republic of Korea.
Kim J; Division of Breast Surgery, Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine, 88, Olympic-ro 43-gil, Songpa-gu, Seoul, 05505, Republic of Korea.
Lee W; Department of Laboratory Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
Ko MS; Health Screening and Promotion Center, Asan Medical Center, Seoul, Republic of Korea.
Choi S; Division of Breast Surgery, Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine, 88, Olympic-ro 43-gil, Songpa-gu, Seoul, 05505, Republic of Korea.
Chang S; Department of Biomedical Sciences, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
Ko CK; R&D Center, NOSQUEST Inc., 660, Daewangpangyo-ro, Bundang-gu, Seongnam-si, Gyeonggi-do, 13494, Republic of Korea.
Lee SB; Division of Breast Surgery, Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine, 88, Olympic-ro 43-gil, Songpa-gu, Seoul, 05505, Republic of Korea. .
Kim DC; R&D Center, NOSQUEST Inc., 660, Daewangpangyo-ro, Bundang-gu, Seongnam-si, Gyeonggi-do, 13494, Republic of Korea. .; Pokaż więcej
Źródło:: Scientific reports [Sci Rep] 2020 Nov 05; Vol. 10 (1), pp. 19136. Date of Electronic Publication: 2020 Nov 05.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Breast Neoplasms/*diagnosis
Neoplasm Recurrence, Local/*diagnosis
Polysaccharides/*metabolism
Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization/*methods
Adult ; Biomarkers/metabolism ; Breast Neoplasms/metabolism ; Breast Neoplasms/pathology ; Female ; Humans ; Middle Aged ; Neoplasm Recurrence, Local/metabolism ; Neoplasm Recurrence, Local/pathology

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 18.

Tytuł:: Analysis of the serial circulating tumor cell count during neoadjuvant chemotherapy in breast cancer patients.
Autorzy:: Gwark S; Department of Surgery, University of Ulsan, College of Medicine, Asan Medical Center, Seoul, Korea.
Kim J; Department of Surgery, University of Ulsan, College of Medicine, Asan Medical Center, Seoul, Korea. .
Kwon NJ; Macrogen Inc, Seoul, Korea.
Kim KY; Macrogen Inc, Seoul, Korea.
Kim Y; Macrogen Inc, Seoul, Korea.
Lee CH; Cytogen Inc, Seoul, Korea.
Kim YH; Cytogen Inc, Seoul, Korea.
Kim MS; Cytogen Inc, Seoul, Korea.
Hong SW; Cytogen Inc, Seoul, Korea.
Choi MY; Cytogen Inc, Seoul, Korea.
Jeon BH; Cytogen Inc, Seoul, Korea.
Chang S; Department of Biomedical Sciences, University of Ulsan, College of Medicine, Asan Medical Center, Seoul, Korea.
Yu J; Department of Surgery, Division of Breast and Endocrine Surgery, Sungkyunkwan University School of Medicine, Samsung Medical Center, Seoul, Korea.
Park JY; Department of Surgery, University of Ulsan, College of Medicine, Asan Medical Center, Seoul, Korea.
Lee HJ; Department of Pathology, University of Ulsan, College of Medicine, Asan Medical Center, Seoul, Korea.
Lee SB; Department of Surgery, University of Ulsan, College of Medicine, Asan Medical Center, Seoul, Korea.
Chung IY; Department of Surgery, University of Ulsan, College of Medicine, Asan Medical Center, Seoul, Korea.
Ko BS; Department of Surgery, University of Ulsan, College of Medicine, Asan Medical Center, Seoul, Korea.
Kim HJ; Department of Surgery, University of Ulsan, College of Medicine, Asan Medical Center, Seoul, Korea.
Lee JW; Department of Surgery, University of Ulsan, College of Medicine, Asan Medical Center, Seoul, Korea.
Son BH; Department of Surgery, University of Ulsan, College of Medicine, Asan Medical Center, Seoul, Korea.
Ahn JH; Department of Oncology, University of Ulsan, College of Medicine, Asan Medical Center, Seoul, Korea.
Jung KH; Department of Oncology, University of Ulsan, College of Medicine, Asan Medical Center, Seoul, Korea.
Kim SB; Department of Oncology, University of Ulsan, College of Medicine, Asan Medical Center, Seoul, Korea.
Gong GY; Department of Pathology, University of Ulsan, College of Medicine, Asan Medical Center, Seoul, Korea.
Ahn SH; Department of Surgery, University of Ulsan, College of Medicine, Asan Medical Center, Seoul, Korea.; Pokaż więcej
Źródło:: Scientific reports [Sci Rep] 2020 Oct 15; Vol. 10 (1), pp. 17466. Date of Electronic Publication: 2020 Oct 15.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Breast Neoplasms/*drug therapy
Neoplasm Recurrence, Local/*pathology
Neoplastic Cells, Circulating/*pathology
Triple Negative Breast Neoplasms/*drug therapy
Adult ; Aged ; Biomarkers, Tumor/metabolism ; Breast Neoplasms/blood ; Cell Count ; Chemotherapy, Adjuvant ; Disease-Free Survival ; Estrogen Receptor alpha/metabolism ; Female ; Follow-Up Studies ; Humans ; MCF-7 Cells ; Microscopy, Fluorescence ; Middle Aged ; Neoadjuvant Therapy ; Neoplasm Recurrence, Local/blood ; Neoplasm, Residual/blood ; Neoplasm, Residual/drug therapy ; Prognosis ; Receptor, ErbB-2/metabolism ; Recurrence ; Treatment Outcome ; Triple Negative Breast Neoplasms/blood

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 19.

Tytuł:: The effects of poloxamer and sodium alginate mixture (Guardix-SG®) on range of motion after axillary lymph node dissection: A single-center, prospective, randomized, double-blind pilot study.
Autorzy:: Lee SB; Division of Breast Surgery, Department of Surgery, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea.
Gwark SC; Division of Breast Surgery, Department of Surgery, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea.
Kang CM; Division of Breast Surgery, Department of Surgery, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea.
Sohn G; Division of Breast Surgery, Department of Surgery, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea.
Kim J; Division of Breast Surgery, Department of Surgery, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea.
Chung IY; Division of Breast Surgery, Department of Surgery, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea.
Lee JW; Division of Breast Surgery, Department of Surgery, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea.
Kim HJ; Division of Breast Surgery, Department of Surgery, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea.
Ko BS; Division of Breast Surgery, Department of Surgery, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea.
Ahn SH; Division of Breast Surgery, Department of Surgery, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea.
Kim W; Department of Rehabilitation Medicine, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea.
Do J; Department of Rehabilitation Medicine, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea.
Jeon JY; Department of Rehabilitation Medicine, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea.
Kim J; Division of Breast Surgery, Department of Surgery, Ulsan University Hospital, Ulsan, Korea.
Um E; Department of Surgery, Inje University Ilsan Paik Hospital, Goyang-si, Gyeonggi-do, Korea.
Yoon TI; Division of Breast Surgery, Department of Surgery, Dongnam institute of Radiological and medical science, Busan, Korea.
Jung SU; Division of Breast Surgery, Department of Surgery, Kosin University Gospel Hospital, Busan, Korea.
Han M; Department of Clinical Epidemiology and Biostatistics, Asan Medical Center, Seoul, Korea.
Son BH; Division of Breast Surgery, Department of Surgery, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea.; Pokaż więcej
Źródło:: PloS one [PLoS One] 2020 Sep 23; Vol. 15 (9), pp. e0238284. Date of Electronic Publication: 2020 Sep 23 (Print Publication: 2020).
Typ publikacji:: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms:: Breast Neoplasms/*surgery
Carboxymethylcellulose Sodium/*administration & dosage
Hyaluronic Acid/*administration & dosage
Lymph Node Excision/*adverse effects
Mastectomy/*adverse effects
Poloxamer/*administration & dosage
Range of Motion, Articular/*drug effects
Shoulder/*pathology
Axilla ; Breast Neoplasms/pathology ; Case-Control Studies ; Double-Blind Method ; Drug Combinations ; Female ; Follow-Up Studies ; Humans ; Lymphatic Metastasis ; Middle Aged ; Pilot Projects ; Prognosis ; Prospective Studies ; Surface-Active Agents/administration & dosage

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 20.

Tytuł:: Breast cancer diagnosis by analysis of serum N-glycans using MALDI-TOF mass spectroscopy.
Autorzy:: Lee SB; Division of Breast Surgery, Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
Bose S; R&D Center, NOSQUEST Inc., Seongnam, Gyeonggi, Republic of Korea.
Ahn SH; Division of Breast Surgery, Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
Son BH; Division of Breast Surgery, Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
Ko BS; Division of Breast Surgery, Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
Kim HJ; Division of Breast Surgery, Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
Chung IY; Division of Breast Surgery, Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
Kim J; Division of Breast Surgery, Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
Lee W; Department of Laboratory Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
Ko MS; Health Screening and Promotion Center, Asan Medical Center, Seoul, Republic of Korea.
Lee K; R&D Center, NOSQUEST Inc., Seongnam, Gyeonggi, Republic of Korea.
Chang S; Department of Biomedical Sciences, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
Park HS; R&D Center, NOSVET Inc., Yongin, Gyeonggi, Republic of Korea.
Lee JW; Division of Breast Surgery, Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
Kim DC; R&D Center, NOSQUEST Inc., Seongnam, Gyeonggi, Republic of Korea.; Pokaż więcej
Źródło:: PloS one [PLoS One] 2020 Apr 09; Vol. 15 (4), pp. e0231004. Date of Electronic Publication: 2020 Apr 09 (Print Publication: 2020).
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Breast Neoplasms/*diagnosis
Polysaccharides/*blood
Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization/*methods
Biomarkers, Tumor/blood ; Breast Neoplasms/blood ; Breast Neoplasms/pathology ; Carcinoma, Ductal, Breast/blood ; Carcinoma, Ductal, Breast/diagnosis ; Case-Control Studies ; Female ; Glycosylation ; Humans ; ROC Curve ; Sensitivity and Specificity

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Informacja

Wyszukujesz frazę ""Lee, Jong Won"" wg kryterium: Autor

Źródło danych

Ogranicz do:

Ogranicz do bazy

Typ dokumentu

Temat

Wydawca

Publikacja

Język

Rok publikacji